Novel adenovirus vaccine vectors lacking thrombosis-associated interactions with platelet factor 4 [PDF]
Summary: The adenoviral vector-based AstraZeneca and Janssen COVID-19 vaccines have been associated with rare cases of thrombosis, believed to be triggered, among other factors, by vector binding to the blood protein platelet factor 4 (PF4).
Erwan Sallard +31 more
doaj +3 more sources
Platelet factor 4 and stromal cell-derived factor are novel prognostic biomarkers for cerebral vasospasm and mortality after subarachnoid hemorrhage [PDF]
Aneurysmal subarachnoid hemorrhage (aSAH) is a life-threatening condition associated with high rates of morbidity and mortality, mainly due to post-hemorrhagic complications such as cerebral vasospasm (CVS) and delayed cerebral ischemia (DCI).
Dilaware Khan +5 more
doaj +4 more sources
Interactions of marine sulfated glycans with antithrombin and platelet factor 4 [PDF]
The molecular interactions of sulfated glycans, such as heparin, with antithrombin (AT) and platelet factor 4 (PF4) are essential for certain biological events such as anticoagulation and heparin induced thrombocytopenia (HIT).
Wenjing Zhang +6 more
doaj +2 more sources
Platelet factor 4 regulation of monocyte KLF4 in experimental cerebral malaria. [PDF]
Cerebral malaria continues to be a difficult to treat complication of Plasmodium falciparum infection in children. We have shown that platelets can have major deleterious immune functions in experimental cerebral malaria (ECM).
Kalyan Srivastava +4 more
doaj +3 more sources
Platelet factor 4 (CXCL4/PF4) upregulates matrix metalloproteinase-2 (MMP-2) in gingival fibroblasts [PDF]
Periodontitis is a chronic inflammatory disease characterized by the release of matrix metalloproteinases (MMPs) from resident connective tissue cells in tooth-supporting tissues (periodontium).
Hoa T. Le +10 more
doaj +2 more sources
Platelet Factor 4: A Mysterious Chemokine in Inflammatory Regulation Diseases [PDF]
Yibing Ji,1,* Qian Zhang,2,* Hua Li,3,* Lixia Chen,3 Yuzhuo Wu,4 Sheng Lin1,2 1College of Pharmacy, Shandong Second Medical University, Weifang, Shandong, 261053, People’s Republic of China; 2Key Laboratory of Chinese Internal Medicine of ...
Ji Y, Zhang Q, Li H, Chen L, Wu Y, Lin S
doaj +2 more sources
Platelet factor 4 induces bone loss by inhibiting the integrin α5‐FAK‐ERK pathway [PDF]
Background The effect of platelet factor 4 (PF4) on bone marrow mesenchymal stem cells (BMMSCs) and osteoporosis is poorly understood. Therefore, this study aimed to evaluate the effects of PF4‐triggered bone destruction in mice and determine the ...
Wei Li +4 more
doaj +2 more sources
Background: Beyond their role in hemostasis and thrombosis, platelets are important for modulating inflammatory reactions. Activated platelets play a role in the pathomechanism of inflammatory diseases such as asthma, but little is known about platelet ...
Risa Tamagawa-Mineoka +4 more
doaj +2 more sources
Platelet Factor 4 Antibodies and Severe AKI. [PDF]
Key Points Patients testing positive for platelet factor 4 antibodies have a >50% higher odds of developing severe AKI compared with those who test negative.The relationship between platelet factor 4 antibodies and severe AKI was independent of demographics, comorbidities, laboratory values,
Thomas C +11 more
europepmc +3 more sources
Anti-Platelet factor 4 immunothrombosis—not just heparin and vaccine triggers [PDF]
Derailments at the tightly regulated interface of blood coagulation and innate inflammatory immune responses can lead to pathologic immunothrombosis. A special subset of immunothrombosis is caused by antibodies against platelet-factor 4 (PF4).
Luisa Müller +4 more
doaj +2 more sources

